Primary small cell neuroendocrine carcinoma (SNEC) of the paranasal sinuses is an extremely rare and distinctive tumor with aggressive clinical behavior. Moreover, SNECs originating in the head and neck region have been reported to be highly aggressive and to have a poor prognosis. This report describes a patient with a maxillary sinus SNEC who was successfully treated with neoadjuvant chemotherapy and concurrent chemoradiotherapy. 1. Introduction Carcinoma developing in the paranasal sinuses accounts for approximately 0.3% of all cancers [1]. Squamous cell carcinoma is by far the most common malignancy, followed by adenocarcinoma. Extrapulmonary small cell neuroendocrine carcinoma (EPSNEC) of sinonasal tract is rare. The first case of SNEC of the paranasal sinuses was reported by Raychowdhuri [2] in 1965. SNECs originating in the head and neck region have been reported to be highly aggressive and to have a poor prognosis. This report describes a patient with a maxillary sinus SNEC who was successfully treated with neoadjuvant chemotherapy and concurrent chemoradiotherapy. The clinical and pathologic features of the tumor and the optimal treatment of this patient are discussed. 2. Case Report A 70-year-old female presented to the oral and maxillofacial department with gradual onset of right cheek swelling around the right gingival and a painful mass for about 1 month. Physical examination showed hard cheek swelling (Figure 1) and epiphora of the right eye, but the patient’s eye movement was normal and she did not have any double vision. The skin around the right eyelids was regular and not reddish, whereas the right posterior alveolar gingival was ulceration ( ) cm, irregular, and reddish in areas (Figure 2). No history of nasal bleed, nasal congestion, and pus from ears. Clinically the patient had an enlarged right submandibular lymph node measuring approximately 3?cm in diameter. The patient was admitted, and imaging studies were performed. Figure 1: Preoperative right cheek swelling. Figure 2: Preoperative intraoral swelling and ulceration. Computed tomography (CT) scan of head showed a large mass measuring approximately 6?cm in diameter in the right maxillary sinus invading the right orbit, ethmoid sinus, and the skin of the cheek (Figures 3(a) and 3(b)). Histologic examination of biopsy sample stained sections showed mucosal tissue bits with features suggestive of poorly differentiated squamous cell carcinoma/neuro-endocrine carcinoma and immunohistochemistry was advised for further evaluation. Immunohistochemical staining was performed on the
References
[1]
S.-F. Huang, W.-Y. Chuang, S.-D. Cheng, L.-J. Hsin, L.-Y. Lee, and H.-K. Kao, “A colliding maxillary sinus cancer of adenosquamous carcinoma and small cell neuroendocrine carcinoma—a case report with EGFR copy number analysis,” World Journal of Surgical Oncology, vol. 8, article 92, 2010.
[2]
R. N. Raychowdhuri, “Oat cell carcinoma and paranasal sinuses,” The Journal of Laryngology and Otology, vol. 79, pp. 253–255, 1965.
[3]
D. Dearnaley, “Small-cell lung cancer: report of a meeting of physicians and scientists at the Royal Marsden Hospital,” The Lancet, vol. 345, pp. 1285–1289, 1995.
[4]
N. B. N. Ibrahim, J. C. Briggs, and C. M. Corbishley, “Extrapulmonary oat cell carcinoma,” Cancer, vol. 54, no. 8, pp. 1645–1661, 1984.
[5]
S. E. Mills, “Neuroectodermal neoplasms of the head and neck with emphasis on neuroendocrine carcinomas,” Modern Pathology, vol. 15, no. 3, pp. 264–278, 2002.
[6]
L. G. Koss, R. H. Spiro, and S. Hajdu, “Small cell (oat cell) carcinoma of minor salivary gland origin,” Cancer, vol. 30, no. 3, pp. 737–741, 1972.
[7]
A. F. Georgiou, D. M. Walker, A. P. Collins, G. J. Morgan, J. A. Shannon, and M. J. Veness, “Primary small cell undifferentiated (neuroendocrine) carcinoma of the maxillary sinus,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology, vol. 98, no. 5, pp. 572–578, 2004.
[8]
W. D. Travis, K. Garg, W. A. Franklin et al., “Bronchioloalveolar carcinoma and lung adenocarcinoma: the clinical importance and research relevance of the 2004 world health organization pathologic criteria,” Journal of Thoracic Oncology, vol. 1, no. 9, pp. S13–S19, 2006.
[9]
A. T. W. Ma and K. I. K. Lei, “Small cell neuroendocrine carcinoma of the ethmoid sinuses presenting with generalized seizure and syndrome of inappropriate antidiuretic hormone secretion: a case report and review of literature,” American Journal of Otolaryngology, vol. 30, no. 1, pp. 54–57, 2009.
[10]
B. Perez-Ordonez, S. M. Caruana, A. G. Huvos, and J. P. Shah, “Small cell neuroendocrine carcinoma of the nasal cavity and paranasal sinuses,” Human Pathology, vol. 29, no. 8, pp. 826–832, 1998.
[11]
E. Babin, V. Rouleau, P. O. Vedrine et al., “Small cell neuroendocrine carcinoma of the nasal cavity and paranasal sinuses,” Journal of Laryngology and Otology, vol. 120, no. 4, pp. 289–297, 2006.
[12]
G. Lo Re, V. Canzonieri, A. Veronesi et al., “Extrapulmonary small cell carcinoma: a single-institution experience and review of the literature,” Annals of Oncology, vol. 5, no. 10, pp. 909–913, 1994.
[13]
J. S. Sierocki, B. S. Hilaris, and S. Hopfan, “cis-Dichlorodiammineplatinum(II) and VP-16-213: an active induction regimen for small cell carcinoma of the lung,” Cancer Treatment Reports, vol. 63, no. 9-10, pp. 1593–1597, 1979.
[14]
J. D. McCracken, L. M. Janaki, J. J. Crowley et al., “Concurrent chemotherapy/radiotherapy for limited small-cell lung carcinoma: a Southwest Oncology Group study,” Journal of Clinical Oncology, vol. 8, no. 5, pp. 892–898, 1990.
[15]
C. A. Perez, L. Einhorn, and R. K. Oldham, “Randomized trial of radiotherapy to the thorax in limited small-cell carcinoma of the lung treated with multiagent chemotherapy and elective brain irradiation: a preliminary report,” Journal of Clinical Oncology, vol. 2, no. 11, pp. 1200–1208, 1984.
[16]
P. A. Bunn Jr., A. S. Lichter, and R. W. Makuch, “Chemotherapy alone or chemotherapy with chest radiation therapy in limited stage small cell lung cancer. A prospective, randomized trial,” Annals of Internal Medicine, vol. 106, no. 5, pp. 655–662, 1987.
[17]
D. I. Rosenthal, J. L. Barker Jr., A. K. El-Naggar et al., “Sinonasal malignancies with neuroendocrine differentiation: patterns of failure according to histologic phenotype,” Cancer, vol. 101, no. 11, pp. 2567–2573, 2004.
[18]
E. G. Silva, J. J. Butler, B. Mackay, and H. Goepfert, “Neuroblastomas and neuroendocrine carcinomas of the nasal cavity. A proposed new classification,” Cancer, vol. 50, no. 11, pp. 2388–2405, 1982.
[19]
G. Han, Z. Wang, X. Guo, M. Wang, H. Wu, and D. Liu, “Extrapulmonary small cell neuroendocrine carcinoma of the paranasal sinuses: a case report and review of the literature,” Journal of Oral and Maxillofacial Surgery, vol. 70, pp. 2347–2351, 2012.
[20]
E. Galanis, S. Frytat, and R. V. Lloyd, “Extrapulmonary small cell carcinoma,” Cancer, vol. 79, pp. 1729–1736, 1997.